Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.

Cited by (491)

Items 101–200 of 491

1. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma
   Antonio Travaglino, Antonio Raffone, Antonio Mollo, Giorgio Borrelli, Pasquale Alfano, Gian Franco Zannoni, Luigi Insabato, Fulvio Zullo · 2020 · Archives of Gynecology and Obstetrics
2. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
   Antonio Travaglino, Antonio Raffone, Diego Raimondo, Damiano Arciuolo, Giuseppe Angelico, Michele Valente, Giulia Scaglione, Nicoletta D’Alessandris, Paolo Casadio, Frediano Socrate Inzani et al. · 2021 · International Journal of Gynecology & Obstetrics
3. Endometrial Cancer: Transitioning from Histology to Genomics
   Cristina Mitric, Marcus Q. Bernardini · 2022 · Current Oncology
4. Molecular characterization of endometrial cancer and therapeutic implications
   Boris J. N. Winterhoff, Lauren Thomaier, Sally A. Mullany, Matthew A. Powell · 2019 · Current Opinion in Obstetrics & Gynecology
5. Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research
   Angiolo Gadducci, Maria Elena Guerrieri · 2017 · Anticancer Research
6. Clear cell carcinoma of the endometrium
   Giorgio Bogani, Isabelle Laure Ray-Coquard, Nicole Concin, Natalie Y.L. Ngoi, Philippe Morice, Takayuki Enomoto, Kazuhiro Takehara, Hannelore Denys, Domenica Lorusso, Robert Coleman et al. · 2022 · Gynecologic Oncology
7. Blinded histopathological characterisation of POLE exonuclease domain‐mutant endometrial cancers: sheep in wolf's clothing
   Inge C. van Gool, Jef E H Ubachs, Ellen Stelloo, Cor Doede de Kroon, Jelle J. Goeman, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Tjalling Bosse · 2017 · Histopathology
8. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis
   Yang Zou, Jiangyan Zhou, Jiu-Bai Guo, Liqun Wang, Yong Luo, Ziyu Zhang, Faying Liu, Jun Tan, Feng Wang, Ouping Huang · 2018 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
9. Update in the molecular classification of endometrial carcinoma
   Alicia León‐Castillo · 2023 · International Journal of Gynecological Cancer
10. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
    Aurélie Auguste, Catherine Genestie, Marco de Bruyn, Julien Adam, Audrey Le Formal, Françoise Drusch, Patricia Pautier, Emma Jayne Crosbie, Helen J MacKay, Henry Charles Kitchener et al. · 2018 · Modern Pathology
11. ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification
    Antonio De Leo, Dario de Biase, Jacopo Lenzi, Giovanna Barbero, Daniela Turchetti, Marco Grillini, Gloria Ravegnini, Sabrina Angelini, Claudio Zamagni, Sara Coluccelli et al. · 2021 · Cancers
12. Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
    Antonio Travaglino, Antonio Raffone, Diego Raimondo, Sabrina Reppuccia, Alessandro Ruggiero, Alessandro Arena, Paolo Casadio, Fulvio Zullo, Luigi Insabato, Renato Seracchioli et al. · 2022 · Archives of Gynecology and Obstetrics
13. Practical issues in the diagnosis of serous carcinoma of the endometrium
    Sónia Gatius, Xavier Matías‐Guiu · 2015 · Modern Pathology
14. Next-Generation Sequencing
    Matthieu Le Gallo, Fred Lozy, Daphne W. Bell · 2016 · Advances in experimental medicine and biology
15. Risk assessment in pulmonary arterial hypertension
    Amresh Raina, Marc J.C. Humbert · 2016 · European Respiratory Review
16. Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Journal of Translational Medicine
17. Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
    Luigi Antonio De Vitis, Gabriella Schivardi, Giuseppe Caruso, Caterina Fumagalli, Davide Vacirca, Maria resa Te Achilarre, Alessia Aloisi, Annalisa Garbi, Vanna L. Zanagnolo, Giovanni Damiano Aletti et al. · 2023 · International Journal of Gynecological Cancer
18. Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
    Kelechi Njoku, Caroline J. J. Sutton, Anthony David Whetton, Emma Jayne Crosbie · 2020 · Metabolites
19. Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer
    Antonio Raffone, Antonio Travaglino, Marco Cerbone, Caterina De Luca, Daniela Russo, Anna Di Maio, Margot De Marco, Maria Caterina Turco, Luigi Insabato, Fulvio Zullo · 2020 · Pathology - Research and Practice
20. Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
    Yuka Asami, Mayumi Kobayashi Kato, Kengo Hiranuma, Maiko Matsuda, Yoko Shimada, Mitsuya Ishikawa, Takafumi Koyama, Masaaki Komatsu, Ryuji Hamamoto, Minoru Nagashima et al. · 2023 · British Journal of Cancer
21. Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study
    Leonora S. F. Boogerd, Charlotte E.S. Hoogstins, Katja N. Gaarenstroom, Cor Doede de Kroon, Jogchum Jan Beltman, Tjalling Bosse, Ellen Stelloo, Jaap Vuyk, Philip Stewart Low, Jacobus Burggraaf et al. · 2017 · Oncotarget
22. Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience
    Kelly A. Devereaux, Julianna J. Weiel, Jennifer Pors, David F. Steiner, Chandler C. Ho, Vivek Charu, Carlos Jose Suarez, Malte Renz, Elisabeth Diver, Amer Karam et al. · 2021 · Modern Pathology
23. FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
    Yvette W. A. Jeske, Shamshad Ali, Sara Ann Byron, Feng Gao, Robert S. Mannel, Rahel G. Ghebre, Paul DiSilvestro, Shashikant Lele, Michael L. Pearl, Amy P. Schmidt et al. · 2017 · Gynecologic Oncology
24. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability
    Tomoko Haruma, Takeshi Nagasaka, Keiichiro Nakamura, Junko Haraga, Akihiro Nyuya, Takeshi Nishida, Ajay Goel, Hisashi Masuyama, Yuji Hiramatsu · 2018 · PLoS ONE
25. Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series
    Francesca Falcone, Nicola Normanno, Simona Losito, Giosuè Scognamiglio, Riziero Esposito Abate, Nicoletta Chicchinelli, Gennaro Casella, Giuseppe Laurelli, Cono Scaffa, Stefano Greggi · 2019 · European Journal of Obstetrics & Gynecology and Reproductive Biology
26. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology
    Mohammed Akhtar, Samir Al Hyassat, Orwa Elaiwy, Sameera Rashid, Ajayeb Dakhilalla M.H. Al-Nabet · 2019 · Advances in Anatomic Pathology
27. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications
    Francesca Addante, Antonio d’Amati, Angela Santoro, Giuseppe Angelico, Frediano Socrate Inzani, Damiano Arciuolo, Antonio Travaglino, Antonio Raffone, Nicoletta D’Alessandris, Giulia Scaglione et al. · 2024 · International Journal of Molecular Sciences
28. Germline BRCA -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
    Marthe M. de Jonge, Lauren L. Ritterhouse, Cor Doede de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal, Rutika Puranik, Harry Hollema, Matti A. Rookus, Christie J. van Asperen, Flora E. van Leeuwen et al. · 2019 · Clinical Cancer Research
29. Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel
    Raquel López-Reig, Antonio Fernández‐Serra, Ignacio Romero, Cristina Zorrero, Carmen Illueca, Zaida García‐Casado, Andres M. Poveda, José Antonio López‐Guerrero · 2019 · Scientific Reports
30. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
    Emily F. Thompson, Jutta K. Huvila, Amy Jamieson, Samuel C. Y. Leung, Amy M. Lum, Saul L. Offman, Alice Lytwyn, Mona Lisa Sur, Lynn N. Hoang, Julie Irving et al. · 2022 · Modern Pathology
31. Reclassifying endometrial carcinomas with a combined morphological and molecular approach
    Joseph W. Carlson, Wilson Glenn McCluggage · 2019 · Current Opinion in Oncology
32. Tumor immune microenvironment in endometrial cancer of different molecular subtypes: evidence from a retrospective observational study
    Yibo Dai, Luyang Zhao, Dingchao Hua, Lina Cui, Xiaobo Zhang, Nan Kang, Linlin Qu, Liwei Li, He Li, Danhua Shen et al. · 2022 · Frontiers in Immunology
33. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women
    Dan He, Hui Wang, Ying Dong, Yan Zhang, Jian Hua Zhao, Conghui Lv, Xianjing Zheng, Dong Li, Ting Li · 2020 · Gynecologic Oncology
34. Inhibiting Wnt/beta‐catenin in CTNNB1‐mutated endometrial cancer
    Marisa R. Moroney, Elizabeth R. Woodruff, Lubna Qamar, Andrew P. Bradford, Rebecca J. Wolsky, Benjamin Guy Bitler, Bradley R. Corr · 2021 · Molecular Carcinogenesis
35. Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
    Amy Jamieson, Jutta K. Huvila, Emily F. Thompson, Samuel C. Y. Leung, Derek S. Chiu, Amy M. Lum, Melissa K. McConechy, Katherine Grondin, Rosalía Aguirre-Hernández, Shannon C. Salvador et al. · 2022 · Gynecologic Oncology
36. Translating biological insights into improved management of endometrial cancer
    Jeffrey How, Amir Anthony Jazaeri, Shannon Neville Westin, Barrett Craig Lawson, Ann H. Klopp, Pamela T. Soliman, Karen H. Lu · 2024 · Nature Reviews Clinical Oncology
37. Microsatellite instability derivedJAK1frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
    Ellen Stelloo, Marco Versluis, Hans W. Nijman, Marco de Bruyn, Annechien Plat, Elisabeth M. Osse, Reinhardt H. van Dijk, Remi A. Nout, Carien L. Creutzberg, Geertruida H. de Bock et al. · 2016 · Oncotarget
38. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
    Pablo García‐Sanz, Juan Carlos Triviño, Alba Mota, María Pérez López, Eva Colás, Alejandro Rojo‐Sebastián, Ángel García, Sónia Gatius, María Ruiz, Jaime Prat et al. · 2016 · International Journal of Cancer
39. Interlaboratory Concordance of ProMisE Molecular Classification of Endometrial Carcinoma Based on Endometrial Biopsy Specimens
    Anna Plotkin, Boris Kuzeljevic, Vanessa De Villa, Emily F. Thompson, C. Blake Gilks, Blaise Alexander Clarke, Martin Köbel, Jessica Nell McAlpine · 2019 · International Journal of Gynecological Pathology
40. Association between genetic polymorphisms and endometrial cancer risk: a systematic review
    Cemsel Bafligil, Deborah J. Thompson, Artitaya Lophatananon, Miriam Jane Smith, Neil A. J. Ryan, Anie Naqvi, D. Gareth Evans, Emma Jayne Crosbie · 2020 · Journal of Medical Genetics
41. Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis
    Shuang Shi, Qiang Tan, Fuqiang Feng, Heping Huang, Jingjie Liang, Dingren Cao, Zhengguang Wang · 2020 · Scientific Reports
42. Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies
    Satoru Kyo, Kentaro Nakayama · 2020 · International Journal of Molecular Sciences
43. A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer
    Ilaria Betella, Caterina Fumagalli, Paola Rafaniello Raviele, Gabriella Schivardi, Luigi Antonio De Vitis, Maria resa Te Achilarre, Alessia Aloisi, Annalisa Garbi, Matteo Maruccio, Vanna L. Zanagnolo et al. · 2022 · International Journal of Gynecological Cancer
44. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis
    Antonio Travaglino, Antonio Raffone, Angela Santoro, Diego Raimondo, Giuseppe Angelico, Michele Valente, Damiano Arciuolo, Giulia Scaglione, Nicoletta D’Alessandris, Paolo Casadio et al. · 2021 · Gynecologic Oncology
45. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
    Amy Jamieson, Jutta K. Huvila, Samuel C. Y. Leung, Derek S. Chiu, Emily F. Thompson, Amy M. Lum, Mary A. Kinloch, Limor Helpman, Shannon C. Salvador, Danielle Vicus et al. · 2023 · Gynecologic Oncology
46. Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor
    Jun-Jun He, Wei Ouyang, Wugan Zhao, Lin Shao, Bing Li, Bihao Liu, Dejuan Wang, Han Han‐Zhang, Zhou Zhang, Liang Shao et al. · 2021 · Annals of Translational Medicine
47. Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma
    Antonio Raffone, Antonio Travaglino, Diego Raimondo, Maria Pia Boccellino, Manuela Maletta, Giulia Borghese, Paolo Casadio, Luigi Insabato, Antonio Mollo, Fulvio Zullo et al. · 2021 · Gynecologic Oncology
48. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
    Stephanie Vrede, Willem Jan van Weelden, Nicole C.M. Visser, Johan Bulten, Louis J.M. van der Putten, Koen K Van de Vijver, Marı́a Santacana, Eva Colás, Antonio Gil‐Moreno, Cristian P. Moiola et al. · 2021 · Gynecologic Oncology
49. Targeting fibroblast growth factor pathways in endometrial cancer
    Boris J. N. Winterhoff, Gottfried E. Konecny · 2016 · Current Problems in Cancer
50. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis
    João Casanova, Gonçalo Silva Duarte, Ana Gomes da Costa, Ana Catarino, Mónica Nave, Telma Antunes, Sofia Silvério Serra, Sara Simões Dias, Nadeem R. Abu‐Rustum, Jorge José Albuquerque Vieira de Lima · 2024 · Gynecologic Oncology
51. Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon
    Nick M. Baniak, Oluwole Fadare, Martin Köbel, John F. DeCoteau, Vinita Parkash, Jonathan L. Hecht, Krisztina Z. Hanley, Katja Gwin, Wenxin Zheng, Charles Matthew Quick et al. · 2018 · The American Journal of Surgical Pathology
52. Improving response to progestin treatment of low-grade endometrial cancer
    Eva Baxter, Donal J. Brennan, Jessica Nell McAlpine, Jennifer Jean Mueller, Frédéric C. Amant, Mignon D J M van Gent, David D. Huntsman, Robert Louis Coleman, Shannon Neville Westin, Melinda S. Yates et al. · 2020 · International Journal of Gynecological Cancer
53. The Perspectives of Fertility Preservation in Women with Endometrial Cancer
    Jure Knez, Leyla Al Mahdawi, Iztok Takač, Monika Sobočan · 2021 · Cancers
54. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative
    Richard John Edmondson, Emma Jayne Crosbie, M. Nickkho‐Amiry, Angelika Kaufmann, Ellen Stelloo, Hans W. Nijman, Alexandra F. Leary, Aurélie Auguste, Linda Mileshkin, Pamela M. Pollock et al. · 2017 · Gynecologic Oncology
55. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
    Martin Köbel, Eshetu G. Atenafu, Peter Rambau, Sarah Elizabeth Ferguson, Gregg S Nelson, T.C. Ho, Tony Panzarella, Jessica Nell McAlpine, C. Blake Gilks, Blaise Alexander Clarke et al. · 2016 · Gynecologic Oncology
56. Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype
    Jutta K. Huvila, Emily F. Thompson, Jamie Vanden Broek, Amy M. Lum, Janine Senz, Samuel C. Y. Leung, C. Blake Gilks, Martin Köbel, Jessica Nell McAlpine, Amy Jamieson · 2023 · Histopathology
57. Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma
    Yuko Sugiyama, Osamu Gotoh, Nobuyuki Fukui, Norio Tanaka, Katsuhiko Hasumi, Yutaka Takazawa, Tetsuo Noda, Seiichi Mori · 2019 · American Journal Of Pathology
58. DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas
    Sheila E. Segura, Silvana Pedra Nobre, Yaser R. Hussein, Nadeem R. Abu‐Rustum, Britta Weigelt, Robert A. Soslow, Deborah F. DeLair · 2020 · The American Journal of Surgical Pathology
59. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis
    Alaa Salah Jumaah, Hawraa Sahib Al‐Haddad, Katherine Ann McAllister, Akeel Abed Yasseen · 2022 · PLoS ONE
60. The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
    Amélia Favier, Justine Varinot, Catherine Uzan, Alex Duval, Isabelle Brochériou, Geoffroy Canlorbe · 2022 · Cancers
61. Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
    Gaia Giannone, Valentina Tuninetti, Eleonora Ghisoni, Sofia Genta, Giulia Scotto, Gloria Mittica, Giorgio Valabrega · 2019 · International Journal of Molecular Sciences
62. Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
    Bastiaan G. Wortman, Remi A. Nout, Tjalling Bosse, Carien L. Creutzberg · 2019 · Current Oncology Reports
63. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape
    Mark A. Glaire, Neil A. J. Ryan, Marieke E. Ijsselsteijn, Katarzyna Kedzierska, Sofia Obolenski, Reem Ali, Emma Jayne Crosbie, Tjalling Bosse, Noel F.C.C. de Miranda, David N. Church · 2022 · The Journal of Pathology
64. An update on the current pharmacotherapy for endometrial cancer
    Christopher de Haydu, Jonathan D. Black, Carlton L. Schwab, Diana Peta-gay English, Alessandro Davide Santin · 2015 · Expert Opinion on Pharmacotherapy
65. The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer
    Yihan Sun, Genyi Jiang, Qianhua Wu, Lei Ye, Bilan Li · 2023 · Frontiers in Oncology
66. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
    Amy Jamieson, Lisa Marie Barroilhet, Jessica Nell McAlpine · 2022 · Cancer
67. Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification
    Emanuele Perrone, Ilaria Capasso, Francesca De Felice, Diana Giannarelli, Giorgia Dinoi, Alessandro Petrecca, Luca Palmieri, Aniello Foresta, Camilla Nero, Damiano Arciuolo et al. · 2023 · European Journal of Cancer
68. Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer
    Jennifer Taylor Veneris, Elizabeth K. Lee, Emily A. Goebel, Marisa R. Nucci, Neal Ian Lindeman, Neil Stuart Horowitz, Larissa J. Lee, Chandrajit P. Raut, David R. Crotzer, Ursula A. Matulonis et al. · 2019 · Gynecologic Oncology
69. Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer
    Lily Proctor, Manohar Pradhan, Samuel C. Y. Leung, Angela S. Cheng, C.H. Lee, Robert A. Soslow, C. Blake Gilks, Aline Talhouk, J. M. McAlpine, Havard Emil Danielsen et al. · 2017 · Gynecologic Oncology
70. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma
    Harald Surowy, A.K. Giesen, J. Otte, Reinhard Büttner, D. Falkenstein, H. Friedl, Friedegund Elke Meier, Patrick Petzsch, Thorsten Wachtmeister, Dana Westphal et al. · 2018 · British Journal of Dermatology
71. Endometrial cancer: a genetic point of view
    Bianca Alves Vieira Bianco, Caio Parente Barbosa, Camila Martins Trevisan, Antonio Simone Laganà, Erik Montagna · 2020 · Translational Cancer Research
72. Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier
    Jutta K. Huvila, Katri J. Orte, Paula Vainio, Tuukka Mettälä, Titta Joutsiniemi, Sakari Hietanen · 2021 · Human Pathology
73. TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review
    Nicoletta D’Alessandris, Antonio Travaglino, Angela Santoro, Damiano Arciuolo, Giulia Scaglione, Antonio Raffone, Frediano Socrate Inzani, Gian Franco Zannoni · 2021 · Gynecologic Oncology
74. A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma
    Kelly A. Devereaux, David F. Steiner, Chandler C. Ho, Adam J. Gomez, C. Blake Gilks, Teri A. Longacre, James L. Zehnder, Brooke E. Howitt, Carlos Jose Suarez · 2021 · International Journal of Gynecological Pathology
75. Real-world outcomes in patients with advanced endometrial cancer: A retrospective cohort study of US electronic health records
    Bradley J. Monk, Gabriella B. Smith, Julianne Lima, Gráinne H. Long, Naufil Alam, Hitomi Nakamura, Didier Meulendijks, Dana Cici Ghiorghiu, Susana N. Banerjee · 2021 · Gynecologic Oncology
76. Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma
    Julie Antomarchi, Damien Ambrosetti, Charlotte Cohen, J. Delotte, Anne Chevallier, B Karimdjee-Soilihi, Mélanie Ngo‐Mai, Annie Schmid‐Alliana, Heidy Schmid‐Antomarchi · 2019 · Cancer Microenvironment
77. Roles of estrogen receptor α in endometrial carcinoma (Review)
    Yidong Ge, Xiaoqi Ni, Jingyun Li, Meng Ye, Xiaofeng Jin · 2023 · Oncology Letters
78. A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
    Simone Marnitz, Till Walter, Birgid Schömig‐Markiefka, Tobias Engler, Stefan Kommoss, Sara Yvonne Brucker · 2020 · Cancers
79. Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
    Marco Versluis, Renske A. de Jong, Annechien Plat, Tjalling Bosse, Vincent T.H.B.M. Smit, Helen J MacKay, Melanie E. B. Powell, Alexandra F. Leary, Linda Mileshkin, Henry Charles Kitchener et al. · 2015 · British Journal of Cancer
80. Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay
    Shuangni Yu, Huilin Shao, Xinchao Ban, Hongkai Zhang, Yan You, Na Zhou, Xinxin Mao, He Zhao, Jie Chen, Zhaohui Lu · 2019 · Frontiers in Oncology
81. Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
    Alaa Salah Jumaah, Hawraa Sahib Al‐Haddad, Mais Muhammed Salem, Katherine Ann McAllister, Akeel Abed Yasseen · 2021 · Journal of Pathology and Translational Medicine
82. Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta‐analysis of survival
    Antonio Raffone, Antonio Travaglino, Diego Raimondo, Manuela Maletta, Valentino De Vivo, Umberto Visiello, Paolo Casadio, Renato Seracchioli, Fulvio Zullo, Luigi Insabato et al. · 2021 · International Journal of Gynecology & Obstetrics
83. Adjuvant treatment of endometrial cancer in molecular era: Are we ready to move on?
    Eduardo Paulino, Andréia Cristina de Melo · 2020 · Critical Reviews in Oncology/Hematology
84. Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
    Gian Franco Zannoni, Emma Bragantini, Francesca Castiglione, Matteo Fassan, Giancarlo Troncone, Frediano Socrate Inzani, Anna Pesci, Angela Santoro, Filippo Fraggetta · 2022 · Frontiers in Oncology
85. Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment
    Pedro Ribeiro-Santos, Carolina Martins Vieira, Gilson Gabriel Viana Veloso, Giovanna Vieira Giannecchini, Martina Parenza Arenhardt, Larissa Müller Gomes, Pedro Henrique da Rocha Zanuncio, Flávio Silva Brandão, Angélica Nogueira‐Rodrigues · 2024 · International Journal of Molecular Sciences
86. Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
    Helen J MacKay, Douglas A. Levine, Victoria Lin Bae-Jump, Daphne W. Bell, Jessica Nell McAlpine, Alessandro Davide Santin, Gini F. Fleming, David Gardner Mutch, Kenneth P. Nephew, Nicolas Wentzensen et al. · 2017 · Oncotarget
87. Unique Molecular Features in High-Risk Histology Endometrial Cancers
    Pooja Pandita, Xiyin Wang, Devin E. Jones, Kaitlyn E. Collins, Shannon M. Hawkins · 2019 · Cancers
88. Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features
    Giovanna Giordano, Elena Ferioli, Debora Guareschi, Alessandro Tafuni · 2023 · Cancers
89. Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition
    Asmerom Tesfamariam Sengal, Vanessa Bonazzi, Deborah S. Smith, Cristian P. Moiola, Rohan Lourie, Rebecca Rogers, Eva Colás, Antonio Gil‐Moreno, Sophia Frentzas, Naven Chetty et al. · 2023 · npj Precision Oncology
90. The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment
    Luigi Antonio De Vitis, Gabriella Schivardi, Susanna Delfrati, Benedetta Biffi, Anna Viscardi, Marina N. Rosanu, Lucia Ribero, Giuseppe Caruso, Alessandra Rappa, Laura Marinucci et al. · 2025 · International Journal of Gynecological Cancer
91. The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning
    Sarah Volinsky-Fremond, Viktor Hendrik Koelzer, Nanda Horeweg, Tjalling Bosse · 2022 · Frontiers in Oncology
92. CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas
    Mónica Pascual-García, Cristina Bértolo, Juan Camilo Nieto, Neus Serrat, Íñigo Espinosa, Emanuela D′Angelo, Raquel Muñoz, Ramón Rovira, Sílvia Vidal, Jaime Prat · 2016 · Human Pathology
93. Molecular Pathology
    Lauren L. Ritterhouse, Brooke E. Howitt · 2016 · Surgical pathology clinics
94. POLE gene hotspot mutations in advanced pancreatic cancer
    Michael Guenther, Vivien Veninga, Joerg Kumbrink, Michael Haas, Christoph Benedikt Westphalen, Stephan Krüger, Volker Heinemann, Thomas Kirchner, Stefan Hubert Boeck, Andreas Jung et al. · 2018 · Journal of Cancer Research and Clinical Oncology
95. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer
    Kumaravel Mohankumar, Xi Li, Subhashree Sridharan, Keshav Karki, Stephen H Safe · 2019 · Gynecologic Oncology
96. Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
    Jenny-Maria Jönsson, Maria Bååth, Ida Björnheden, İrem Durmaz, Anna Måsbäck, Ingrid A. Hedenfalk · 2021 · Cancers
97. Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
    Regina Esi Mensimah Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts, Frédéric C. Amant · 2021 · Cancers
98. Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
    Masako Ishikawa, Kentaro Nakayama, Kohei Nakamura, Ruriko Ono, Kaori Sanuki, Hitomi Yamashita, Tomoka Ishibashi, Toshiko Minamoto, Kouji Iida, Sultana Razia et al. · 2018 · Oncotarget
99. Low-Risk and High-Risk NSMPs: A Prognostic Subclassification of No Specific Molecular Profile Subtype of Endometrial Carcinomas
    Matteo Marchetti, Giulia Spagnol, Tommaso Vezzaro, Sofia Bigardi, Orazio De Tommasi, Emma Facchetti, Marta Tripepi, Diletta Costeniero, Chiara Munerol, Tiziano Maggino et al. · 2024 · Cancers
100. Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective
     Guoli Chen, Zhaohai Yang, James R. Eshleman, George Jabboure Netto, Ming‐Tseh Lin · 2016 · BioMed Research International